We are excited to be expanding the Cancer Academy into the cross-cutting field of Acute Oncology (AO). We are working in conjunction with both the AO cancer alliance pathway board and other site specific pathway boards to deliver education both specifically for the AO workforce and anyone who may interact with patients experiencing an oncological emergency.
In development are several interactive modules around Metastatic Spinal Cord Compression, an upcoming pathway board education and engagement event, and are also scoping a cross-academy collaborative module with the Neuro-Oncology Academy.
This course will cover the timely and accurate diagnosis of MSCC for patients. For patients with an existing cancer diagnosis, this is critical as MSCC can be more difficult to diagnose.
This module covers what MSCC is (detection, diagnosis, treatment and follow up care), and how it is managed clinically.
This module focuses on the triaging process and treatment options. This module offers guidance on initially managing suspected MSCC and who to contact following confirmed diagnosis and rehabilitation.
This module focuses on rehabilitation and advanced care planning. It offers guidance around the management options for common MSCC symptoms and it offers information around supportive care.
Short, snappy online session that can be watched live (where questions can be asked to our speakers) or on-demand. Watch this space for future webinars and updates.
This webinar will provide education and information on the new MSCC Lung Cancer Pathway in Greater Manchester, East & Mid Cheshire.
The pathway will promote team working between MSCC Co-ordinators, Acute Oncology Nurses & Lung Cancer Nurses. It will promote importance of rapid pathological diagnosis before considering surgery, exclude small cell and look for better prognostic groups via ctDNA (high false positive rate) and tissue biopsy to look for drivers and obtain PDL1. For patients will no neurology and good performance status the priority is to quickly receive SACT and likely to offer radiotherapy. Patients will be considered on a case by case basis for surgery where no pathological diagnosis is possible, low comorbidity and spinal instability or potentially reversible / changing neurology affecting performance status for imminent SACT.
This webinar aims to provide confidence for peripheral hospital medical teams or managing patients with brain metastases and is aimed to offer as much practical advice as possible.
Suitable for Hospital Doctors, Nurses and Allied Health Professionals involved in the management of patients with brain metastases.
This on-demand event focuses on best practices and ongoing developments via the Greater Manchester Cancer Alliance Acute Oncology Pathway Board.
View the agenda below and watch on-demand around your schedule.
The UK Acute Oncology Competence Assessment Passports aim to promote the development of a knowledgeable, skilled, and competent workforce that treats and cares for people with an acute oncology indication. The Level 1 Passport has been developed into an online resource in collaboration with Macmillan Cancer Support.
The resource is currently being piloted and includes pre and post course learning surveys. It maps to the Level 1 framework within the UKONS Acute Oncology Knowledge and Skills Guidance and learners will receive a certificate on completion.
Use the information in the flyers below to access the e-learning module on the Macmillan Learning Hub. Please feel free to circulate the below materials with any relevant networks.
This Digital Level 1 resource is part of a wider national project developing acute oncology competence assessment documents.
This is a promotional website, developed and funded by Chugai Pharma UK Ltd.
The CINV academy educational programme is a series of e-learning modules created in collaboration with expert nurses and pharmacists and has been initiated and developed by Chugai for healthcare professionals. The CINV academy will provide you with a comprehensive understanding of CINV physiology, treatments (including promotional content relating to anti- emetic products promoted by Chugai) and patient related risk factors. It will assist you with making key decisions in the management of CINV across the patient pathway.
The course contains 4 modules: